Interestingly, in the molecular classification of Lei et al. distinguishing GC into proliferative, metabolic, and mesenchymal subtypes [6], tumors of the mesenchymal phenotype, which are enriched in cells with features of CSCs, are particularly sensitive to PI3K/AKT/mTOR inhibitors in vitro [6]. This evidence concerns the gene MTOR and gastric cancer.